| Product Code: ETC7277244 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia Antithrombotic Drugs Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Georgia Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Georgia Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Georgia Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Georgia |
4.2.2 Growing aging population in the country |
4.2.3 Rising awareness about the importance of antithrombotic drugs in preventing blood clots |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Georgia |
4.3.2 High cost associated with antithrombotic drugs |
4.3.3 Potential side effects and risks associated with prolonged use of antithrombotic drugs |
5 Georgia Antithrombotic Drugs Market Trends |
6 Georgia Antithrombotic Drugs Market, By Types |
6.1 Georgia Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Georgia Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Georgia Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Georgia Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Georgia Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Georgia Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Georgia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Georgia Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Georgia Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Georgia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Georgia Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Georgia Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Georgia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Georgia Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Georgia Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Georgia Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Georgia Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Georgia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Georgia Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Georgia Antithrombotic Drugs Market Export to Major Countries |
7.2 Georgia Antithrombotic Drugs Market Imports from Major Countries |
8 Georgia Antithrombotic Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for antithrombotic drugs in Georgia |
8.2 Patient adherence rate to antithrombotic drug therapy |
8.3 Rate of hospitalizations due to thrombotic events in Georgia |
9 Georgia Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Georgia Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Georgia Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Georgia Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Georgia Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Georgia Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Georgia Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Georgia Antithrombotic Drugs Market - Competitive Landscape |
10.1 Georgia Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Georgia Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here